Entities / Person
Michael Henderson.
vehicle safety researcher
- Reports this week
- 0
- Active events
- 0
- Connections
- 7
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Michael Henderson was appointed Senior Client Advisor and Head of Investments at Whitechapel Securities.Some support2 reports
-
Apogee Therapeutics conducted the Phase 2 APEX clinical trial for its anti-IL-13 antibody, APG777.Speculative1 report
-
Michael Henderson has been appointed as the CEO of Apogee Therapeutics.Some support1 report
No events began in the chosen period. Widen it, or reset.
Connections
The 1 strongest of 7, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Louisiana State University Structural
Michael Henderson is employed as a professor of political communication at Louisiana State University.